Makjai Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-12-2024
- Paid Up Capital ₹ 0.50 M
as on 04-12-2024
- Company Age 27 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2022)
- Profit -17.14%
(FY 2022)
- Ebitda -30.98%
(FY 2022)
- Net Worth -2.03%
(FY 2022)
- Total Assets -4.50%
(FY 2022)
About Makjai Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Mohan Mulherkar, Makarand Mulherkar, Veena Mulherkar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232MH1997PLC111422
- Company No.
111422
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Oct 1997
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Makjai Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Makarand Mulherkar  | Director | 01-Jun-2022 | Current |
| Meenal Makarand | Director | 18-Apr-2019 | Current |
| Mohan Mulherkar | Director | 01-Nov-2021 | Current |
| Veena Mulherkar | Director | 21-Oct-1997 | Current |
Financial Performance of Makjai Pharmaceuticals.
Makjai Pharmaceuticals Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 17.14% decrease in profit. The company's net worth dipped by a decrease of 2.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Makjai Pharmaceuticals?
In 2019, Makjai Pharmaceuticals had a promoter holding of 99.70% and a public holding of 0.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Makjai Laboratories Pvt LtdActive 32 years 3 monthsMohan Mulherkar, Makarand Mulherkar and 2 more are mutual person
Makjai Airlines LimitedActive 17 years 2 monthsMohan Mulherkar, Makarand Mulherkar and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Makjai Pharmaceuticals?
Unlock and access historical data on people associated with Makjai Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Makjai Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Makjai Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
